Replies to post #113324 on Biotech Values

[dewophile]

thanks for the expert insights

just to clarify if a development process that uses mnta's US patents is performed ex-US that they then use to reverse engineer a production process of their own - as long as the production process itself doesn't then infringe the product woudl not infringe when brought into the US. however, my understanding is that built into the production process are validation processes to ensure product meets specifications. even if the production process does not infringe, and was based on work done ex-us, if ongoing validation uses mnta's processes ex-US for commercial product would you think that product when sold in the US would be deemed to infringe?